Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Observational

Oxygen Saturation Monitoring During Transport Between the Operating Room and the Post-anesthesia Care Unit

NCT07313488 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2025-05-20
Last updated
2026-01-02

Condition(s) studied

Surgery

Study summary

To evaluate whether continuous SpO₂ monitoring during transfer between the operating room and the Post-Anesthesia Care Unit (PACU) reduces the incidence of desaturations

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult patient (≥ 18 years old) * Patient scheduled for surgery under general anesthesia at the HUS between January 1, 2024 and April 30, 2025 Exclusion Criteria: \- Administration of premedication that may impair judgment.

Primary outcome measure(s)

  • Reduction of the incidence of desaturations — upon Arrival in the Recovery Room
    To evaluate whether continuous SpO₂ monitoring during transfer between the operating room and the PACU reduces the incidence of desaturations by recording: * The last SpO₂ reading taken upon leaving the operating room * The first SpO₂ reading taken upon arrival in the recovery room * The lowest SpO₂ reading taken during the transfer between the operating room and the recovery room (for patients monitored by pulse oximetry)

Trial sites (1)

FacilityCityRegionStatus
Service d'Anesthésie - CHU de Strasbourg - France Strasbourg France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07313488 on ClinicalTrials.gov ↗ ← All trials in France